microdosing tirzepatide Compounded Microdosing Tirzepatide: Gentle GLP-1, Dosing

Milech et al

Tirzepatide is a dual GLP-1/GIP agonist it addresses appetite, insulin sensitivity, fat metabolism, and energy expenditure simultaneously Cagrilintide targets amylin receptors in the brain for powerful appetite suppression, but without the broader metabolic benefits seen with Tirzepatide

Growth hormone then causes the liver to secrete hormones like insulin-like growth factor 1 (IGF-1), which promotes cell growth and tissue repair, and supports longevity

Every protocol starts with a consultation, uses 503A pharmacy sourcing, and includes provider monitoring throughout

This offers: faster uptake higher bioavailability a convenient, needlefree alternative a practical option for daily antioxidant support Sublingual use is ideal for personal wellness routines, travel, maintenance between IV sessions, or for individuals who prefer noninvasive delivery